Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Trial to Evaluate the Efficacy and Safety of Once Daily Diclofenac Gel AMZ001 in the Treatment of Pain and Symptoms of Knee Osteoarthritis

NCT06693648 is registered in ClinicalTrials.gov with Amzell as lead sponsor.

NCT NCT06693648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06693648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Trial to Evaluate the Efficacy and Safety of Once Daily Diclofenac Gel AMZ001 in the Treatment of Pain and Symptoms of Knee Osteoarthritis
Lead sponsor
Amzell
Phase
Phase 3
Overall status
Completed
Start date
February 18, 2025
Completion date
April 13, 2026
Enrollment
549 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of knee, osteoarthritis, knee